
Sign up to save your podcasts
Or


Ozempic and other GLP-1 treatments began as medications for Type 2 diabetes, but have spread in popularity as weight-loss drugs. Dr. Akshay Jain, endocrinologist and diabetes advocate, joins the show to answer viewer questions about weight-loss drugs.
By CBC4.3
88 ratings
Ozempic and other GLP-1 treatments began as medications for Type 2 diabetes, but have spread in popularity as weight-loss drugs. Dr. Akshay Jain, endocrinologist and diabetes advocate, joins the show to answer viewer questions about weight-loss drugs.

19,040 Listeners

433 Listeners

396 Listeners

152 Listeners

236 Listeners

47 Listeners

222 Listeners

70 Listeners

788 Listeners

78 Listeners

26 Listeners

7,520 Listeners

114 Listeners

774 Listeners

10,228 Listeners

95 Listeners

469 Listeners

27 Listeners

3,486 Listeners

21 Listeners

628 Listeners

129 Listeners